Journal article

Cardiorenal protective effects of vasopeptidase inhibition with omapatrilat in hypertensive transgenic (mREN-2)27 rats

SA Mifsud, LM Burrell, E Kubota, K Jaworski, ME Cooper, JL Wilkinson-Berka

Clinical and Experimental Hypertension | TAYLOR & FRANCIS INC | Published : 2004

DOI: 10.1081/CEH-120027332

Citation metrics

11Web of Science
11Scopus

Keywords

Blood Pressure
Omapatrilat
Male
Angiotensin-Converting Enzyme
Pyridines
(mren-2)27 Rat
Body Weight
Cardiovascular System & Cardiology
Atrial Natriuretic Factor
Heart-Failure
Thiazepines
Life Sciences & Biomedicine
Antihypertensive Agents
Treatment Outcome
Animals
Animals, Genetically Modified
Science & Technology
Fosinopril
Renin Gene
Neutral Endopeptidase
Cardiomegaly
Angiotensin-Converting Enzyme Inhibitors
Kidney
Blockade
Fibrosis
Neprilysin
Systole
Hypertension
Survival Analysis
Dose-Response Relationship, Drug
Time Factors
Models, Cardiovascular
Mdl-100,240
Receptor
Lisinopril
Renin
Rats
Biomarkers
Peripheral Vascular Disease
Disease Models, Animal
Blood-Pressure
Nephropathy
Pharmacology & Pharmacy
Statistics As Topic